Trademark: 97016577
Word
INVICRO
Status
Pending
Status Code
730
Status Date
Wednesday, December 13, 2023
Serial Number
97016577
Mark Type
3000
Filing Date
Wednesday, September 8, 2021
Published for Opposition
Tuesday, April 25, 2023

Trademark Owner History
Invicro, LLC - Owner At Publication

Classifications
41 Educational services, namely, developing, arranging and conducting educational programs, panel discussions and non-downloadable webinars in the fields of pharmaceuticals, biotechnology, pre-clinical and clinical trials, and medical research; educational services, namely, providing non-downloadable publications in the nature of blogposts and magazines, and non-downloadable literature in the nature of periodicals and books in the fields of pharmaceuticals, biotechnology, pre-clinical and clinical trials, and medical research
40 Processing of medical images, namely, labeling, alteration and retouching of medical photographic images
9 Downloadable computer software for processing, visualizing, storing and analyzing pre-clinical and clinical radiology and pathology image data in the fields of drug development and disease research; downloadable computer software for image data management purposes, namely, pre-clinical and clinical image database management and research subject records management; downloadable computer software for processing multi-modal imaging data; downloadable computer software for the processing, storage and analysis of multi-modal imaging data for quantitation and evaluation of biomarkers and drug candidates; downloadable software for the assessment of tumors for research through use of biomarkers
35 Medical and scientific research, namely, conducting pre-clinical trial services for others in the nature of recruitment advertising services in the nature of posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs
44 Medical imaging services; medical imaging and radiology services related to drug development, namely, medical imaging and radiology services of clinical trial patients for medical purposes; image analysis and radiology, namely, analysis of images from all radiological modalities, such as but not limited to CT, MRI and PET scans to provide quantitative evaluation of drug candidates medical radiology, namely, molecular imaging, imaging utilizing radiopharmaceuticals for the diagnosis and medical treatment of trial candidates; radiomics, namely, medical radiology services; medical imaging services, namely, medical imaging and extraction of imaging biomarkers; analysis of medical images, namely, medical analysis of medical images for diagnosis and treatment of persons in clinical trials
42 Medical and scientific research, namely, conducting clinical trial services for others and pre-clinical trial services for others in the nature of testing of pharmaceuticals; pharmaceutical research and development services; testing of pharmaceutical pharmacodynamics, pharmacokinetics and efficacy using a variety of imaging modalities and imaging analysis platforms; imaging services and pathology in support of pharmaceutical research and development, namely, research of disease and non-medical ultrasound imaging services, all for the research and development of pharmaceuticals; drug discovery services; conducting early evaluations in the field of new drugs; scientific investigations for medical research purposes; medical and scientific research laboratory services; medical and scientific research, namely, providing analysis of imaging data obtained from pre-clinical and clinical trial studies; medical and scientific research in the fields of medical radiology imaging, pathology and digital pathology; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; research and development in the fields of medical imaging, pharmaceuticals and biotechnology; design, development, maintenance and updating of computer software for image processing, storage and analysis in the fields of pharmaceuticals and biotechnology; electronic storage of medical images; processing of medical images, namely, digital image interpretation for scientific research and medical research purposes, labeling, correction, restoration and enhancement; pathology services in support of drug development, namely, medical research regarding diseases for the purpose of developing drugs; hosting of a medical imaging analysis and visualization platform in the nature of a website through a global computer network; hosting of digital content on the Internet, namely, hosting of a database of medical images; software as a service (SAAS) featuring computer software platforms for image processing, storage and analysis in the fields of pharmaceuticals and biotechnology; conducting clinical trials for others at all stages and in various indications, particularly in oncology, neurology and systemic diseases; imaging contract research organization services and technology solutions, namely, non-medical ultrasound imaging services for medical and scientific research purposes and technology solutions, namely, reviewing of radiology images throughout the clinical trial process and blinded independent central review of radiology images in the medical research and clinical trial setting for medical research and scientific research purposes; scientific research services, namely, integration of imaging results with clinical outcome data, with application of machine learning and artificial intelligence applications; development and evaluation in the nature of testing of imaging biomarkers for clinical trial purposes; software consulting services in the field of drug discovery; cloud computing featuring software for use in database management for use in pharmaceutical drug research in the field of drug discovery; radiochemistry services in the nature of radiolabeling for scientific research and medical research purposes and radiochemical analysis; research, development and testing services relating to radiopharmaceuticals; radiolabeling scientific research, namely, labeling of both small molecules and biologics; providing non-downloadable web-based computer software for database management in the fields of medical imaging, pharmaceutical and biotechnology research; medical imaging and radiology services related to drug development, namely, medical imaging and radiology services of clinical trial patients for research purposes; medical and scientific research services in the fields of magnetic resonance and molecular imaging; medical research services, in particular services relating to the development of radiotherapeutics and drug candidates for neurodegenerative diseases and precision oncology; image analysis and radiology, namely, analysis of images from all radiological modalities, such as but not limited to CT, MRI and PET scans, to provide quantitative evaluation of drug candidates medical radiology, namely, molecular imaging, imaging utilizing radiopharmaceuticals for medical research and pharmaceutical development purposes; pathology services, namely, testing for research purposes in the fields of pharmaceuticals and biotechnology; pathology services for preclinical biomarker discovery research and clinical trials
The mark consists of an image of an overhead shot of a magnifying glass with a loupe in the circle with the word "INVICRO" to the right of the image.

Trademark Events
Dec 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 13, 2023
Sou Extension 1 Granted
Dec 13, 2023
Sou Extension 1 Filed
Dec 13, 2023
Sou Teas Extension Received
Jun 20, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 25, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 25, 2023
Published For Opposition
Apr 5, 2023
Notification Of Notice Of Publication E-Mailed
Mar 17, 2023
Approved For Pub - Principal Register
Mar 17, 2023
Examiner's Amendment Entered
Mar 17, 2023
Notification Of Examiners Amendment E-Mailed
Mar 17, 2023
Examiners Amendment E-Mailed
Mar 17, 2023
Examiners Amendment -Written
Mar 13, 2023
Teas/Email Correspondence Entered
Mar 13, 2023
Correspondence Received In Law Office
Mar 11, 2023
Assigned To Lie
Jan 11, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 11, 2023
Teas Change Of Correspondence Received
Jan 11, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 11, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 11, 2023
Teas Change Of Owner Address Received
Dec 29, 2022
Teas Response To Office Action Received
Dec 6, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 6, 2022
Teas Change Of Correspondence Received
Dec 6, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 6, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 6, 2022
Teas Change Of Owner Address Received
Jun 29, 2022
Notification Of Non-Final Action E-Mailed
Jun 29, 2022
Non-Final Action E-Mailed
Jun 29, 2022
Non-Final Action Written
Jun 13, 2022
Assigned To Examiner
Oct 19, 2021
Notice Of Design Search Code E-Mailed
Oct 18, 2021
New Application Office Supplied Data Entered
Sep 11, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24